Cargando…

Serum Autoantibody Profiling of Patients with Paraneoplastic and Non-Paraneoplastic Autoimmune Retinopathy

PURPOSE: Although multiple serum antiretinal autoantibodies (ARAs) have been reported in patients with paraneoplastic and non-paraneoplastic autoimmune retinopathy ((n)pAIR), not all retinal antigens involved in (n)pAIR are specified. This study aims to serologically identify patients with presumed...

Descripción completa

Detalles Bibliográficos
Autores principales: ten Berge, Josianne C., van Rosmalen, Joost, Vermeer, Jacolien, Hellström, Cecilia, Lindskog, Cecilia, Nilsson, Peter, Qundos, Ulrika, Rothova, Aniki, Schreurs, Marco W. J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5145218/
https://www.ncbi.nlm.nih.gov/pubmed/27930731
http://dx.doi.org/10.1371/journal.pone.0167909
_version_ 1782473258374791168
author ten Berge, Josianne C.
van Rosmalen, Joost
Vermeer, Jacolien
Hellström, Cecilia
Lindskog, Cecilia
Nilsson, Peter
Qundos, Ulrika
Rothova, Aniki
Schreurs, Marco W. J.
author_facet ten Berge, Josianne C.
van Rosmalen, Joost
Vermeer, Jacolien
Hellström, Cecilia
Lindskog, Cecilia
Nilsson, Peter
Qundos, Ulrika
Rothova, Aniki
Schreurs, Marco W. J.
author_sort ten Berge, Josianne C.
collection PubMed
description PURPOSE: Although multiple serum antiretinal autoantibodies (ARAs) have been reported in patients with paraneoplastic and non-paraneoplastic autoimmune retinopathy ((n)pAIR), not all retinal antigens involved in (n)pAIR are specified. This study aims to serologically identify patients with presumed (n)pAIR through determination of both known and unknown ARAs by autoantibody profiling. METHODS: An antigen suspension bead array using 188 different antigens representing 97 ocular proteins was performed to detect ARAs in serum samples of patients with presumed (n)pAIR (n = 24), uveitis (n = 151) and cataract (n = 21). Logistic regressions were used to estimate the associations between ocular antigens and diagnosis. Validation of interphotoreceptor matrix proteoglycan 2 (IMPG2) and recoverin antigens was performed by immunohistochemistry and immunoblot, respectively. RESULTS: Samples of patients with presumed (n)pAIR exhibited a broad spectrum of ARAs. We identified retinal antigens that have already been described previously (e.g. recoverin), but also identified novel ARA targets. Most ARAs were not specific for (n)pAIR since their presence was also observed in patients with cataract or uveitis. High titers of autoantibodies directed against photoreceptor-specific nuclear receptor and retinol-binding protein 3 were more common in patients with presumed (n)pAIR compared to uveitis (p = 0.015 and p = 0.018, respectively). The presence of all other ARAs did not significantly differ between groups. In patients with presumed (n)pAIR, anti-recoverin autoantibodies were the most prevalent ARAs. Validation of bead array results by immunohistochemistry (anti-IMPG2) and immunoblot (anti-recoverin) showed concordant results in (n)pAIR patients. CONCLUSIONS: Patients with (n)pAIR are characterized by the presence of a broad spectrum of ARAs. The diagnosis of (n)pAIR cannot be based on the mere presence of serum ARAs, as these are also commonly present in uveitis as well as in age-related cataract patients.
format Online
Article
Text
id pubmed-5145218
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Public Library of Science
record_format MEDLINE/PubMed
spelling pubmed-51452182016-12-22 Serum Autoantibody Profiling of Patients with Paraneoplastic and Non-Paraneoplastic Autoimmune Retinopathy ten Berge, Josianne C. van Rosmalen, Joost Vermeer, Jacolien Hellström, Cecilia Lindskog, Cecilia Nilsson, Peter Qundos, Ulrika Rothova, Aniki Schreurs, Marco W. J. PLoS One Research Article PURPOSE: Although multiple serum antiretinal autoantibodies (ARAs) have been reported in patients with paraneoplastic and non-paraneoplastic autoimmune retinopathy ((n)pAIR), not all retinal antigens involved in (n)pAIR are specified. This study aims to serologically identify patients with presumed (n)pAIR through determination of both known and unknown ARAs by autoantibody profiling. METHODS: An antigen suspension bead array using 188 different antigens representing 97 ocular proteins was performed to detect ARAs in serum samples of patients with presumed (n)pAIR (n = 24), uveitis (n = 151) and cataract (n = 21). Logistic regressions were used to estimate the associations between ocular antigens and diagnosis. Validation of interphotoreceptor matrix proteoglycan 2 (IMPG2) and recoverin antigens was performed by immunohistochemistry and immunoblot, respectively. RESULTS: Samples of patients with presumed (n)pAIR exhibited a broad spectrum of ARAs. We identified retinal antigens that have already been described previously (e.g. recoverin), but also identified novel ARA targets. Most ARAs were not specific for (n)pAIR since their presence was also observed in patients with cataract or uveitis. High titers of autoantibodies directed against photoreceptor-specific nuclear receptor and retinol-binding protein 3 were more common in patients with presumed (n)pAIR compared to uveitis (p = 0.015 and p = 0.018, respectively). The presence of all other ARAs did not significantly differ between groups. In patients with presumed (n)pAIR, anti-recoverin autoantibodies were the most prevalent ARAs. Validation of bead array results by immunohistochemistry (anti-IMPG2) and immunoblot (anti-recoverin) showed concordant results in (n)pAIR patients. CONCLUSIONS: Patients with (n)pAIR are characterized by the presence of a broad spectrum of ARAs. The diagnosis of (n)pAIR cannot be based on the mere presence of serum ARAs, as these are also commonly present in uveitis as well as in age-related cataract patients. Public Library of Science 2016-12-08 /pmc/articles/PMC5145218/ /pubmed/27930731 http://dx.doi.org/10.1371/journal.pone.0167909 Text en © 2016 ten Berge et al http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/4.0/) , which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Research Article
ten Berge, Josianne C.
van Rosmalen, Joost
Vermeer, Jacolien
Hellström, Cecilia
Lindskog, Cecilia
Nilsson, Peter
Qundos, Ulrika
Rothova, Aniki
Schreurs, Marco W. J.
Serum Autoantibody Profiling of Patients with Paraneoplastic and Non-Paraneoplastic Autoimmune Retinopathy
title Serum Autoantibody Profiling of Patients with Paraneoplastic and Non-Paraneoplastic Autoimmune Retinopathy
title_full Serum Autoantibody Profiling of Patients with Paraneoplastic and Non-Paraneoplastic Autoimmune Retinopathy
title_fullStr Serum Autoantibody Profiling of Patients with Paraneoplastic and Non-Paraneoplastic Autoimmune Retinopathy
title_full_unstemmed Serum Autoantibody Profiling of Patients with Paraneoplastic and Non-Paraneoplastic Autoimmune Retinopathy
title_short Serum Autoantibody Profiling of Patients with Paraneoplastic and Non-Paraneoplastic Autoimmune Retinopathy
title_sort serum autoantibody profiling of patients with paraneoplastic and non-paraneoplastic autoimmune retinopathy
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5145218/
https://www.ncbi.nlm.nih.gov/pubmed/27930731
http://dx.doi.org/10.1371/journal.pone.0167909
work_keys_str_mv AT tenbergejosiannec serumautoantibodyprofilingofpatientswithparaneoplasticandnonparaneoplasticautoimmuneretinopathy
AT vanrosmalenjoost serumautoantibodyprofilingofpatientswithparaneoplasticandnonparaneoplasticautoimmuneretinopathy
AT vermeerjacolien serumautoantibodyprofilingofpatientswithparaneoplasticandnonparaneoplasticautoimmuneretinopathy
AT hellstromcecilia serumautoantibodyprofilingofpatientswithparaneoplasticandnonparaneoplasticautoimmuneretinopathy
AT lindskogcecilia serumautoantibodyprofilingofpatientswithparaneoplasticandnonparaneoplasticautoimmuneretinopathy
AT nilssonpeter serumautoantibodyprofilingofpatientswithparaneoplasticandnonparaneoplasticautoimmuneretinopathy
AT qundosulrika serumautoantibodyprofilingofpatientswithparaneoplasticandnonparaneoplasticautoimmuneretinopathy
AT rothovaaniki serumautoantibodyprofilingofpatientswithparaneoplasticandnonparaneoplasticautoimmuneretinopathy
AT schreursmarcowj serumautoantibodyprofilingofpatientswithparaneoplasticandnonparaneoplasticautoimmuneretinopathy